GlassScriptPhysician profile
Radha Samtani
NPI 1144882044
$3,718.26
in general payments reported to CMS, 2019-2025
38 companies · $2,240 in 2025
The $2,240 reported for 2025 was more than what 95% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $231 · 2023: $599 · 2024: $648 · 2025: $2,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,804 · Consulting Fee: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,804.45 |
| Consulting Fee | $682.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $993.58 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Eisai INC. | $763.33 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $398.95 | 2023-2025 | Lynparza, Tagrisso, Calquence |
| Janssen Biotech, INC. | $245.73 | 2022-2025 | Rybrevant, Imbruvica |
| Genentech USA, INC. | $177.00 | 2022-2025 | Tecentriq, Venclexta |
| Glaxosmithkline, LLC. | $134.39 | 2022-2025 | Zejula, Jemperli |
| Pfizer INC. | $88.45 | 2023-2025 | |
| Exelixis INC. | $83.68 | 2025 | Cabometyx |
| Coherus Oncology, INC. | $65.52 | 2023-2025 | Loqtorzi |
| Daiichi Sankyo INC. | $60.48 | 2024-2025 | Enhertu, Vanflyta, Injectafer |
| Servier Pharmaceuticals LLC | $50.24 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $42.52 | 2023-2025 | |
| Abbvie INC. | $41.69 | 2025 | |
| Seagen INC. | $40.97 | 2023 | Tukysa |
| Incyte Corporation | $36.75 | 2025 | Monjuvi, Zynyz |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radha Samtani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.